Uveitis Treatment Market in Asia Pacific is expected to register a CAGR of 6.7% during the forecast period (2019-2025) - KBV Research

16-Apr-2020 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Asia Pacific Uveitis Treatment Market, published by KBV research, the Asia Pacific Uveitis Treatment Market would witness market growth of 6.7% CAGR during the forecast period (2019-2025).

The China market dominated the Asia Pacific Online stores Market by Country in 2018, and would continue to be a dominant market till 2025. The Japan market is experiencing a CAGR of 7.8% during (2019 - 2025). Additionally, The India market is poised to grow at a CAGR of 7.8% during (2019 - 2025).

The Anti-inflammatory market dominated the South Korea Uveitis Treatment Market by Drug Class in 2018, thereby, achieving a market value of $7.9 million by 2025, growing at a CAGR of 6.8 % during the forecast period. The Immunotherapy & Targeted Therapies market is expected to witness a CAGR of 7.6% during (2019 - 2025).

The Anterior Uveitis market dominated the Singapore Uveitis Treatment Market by Disease Type in 2018, growing at a CAGR of 6.9 % during the forecast period. The Posterior Uveitis market would witness a CAGR of 7.9% during (2019 - 2025).

Structural Insights: https://www.kbvresearch.com/asia-pacific-uveitis-treatment-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.

Asia Pacific Uveitis Treatment Market Segmentation

By Drug Class

  • Anti-inflammatory
  • Immunotherapy & Targeted Therapies
  • Antimicrobial Drugs
  • Other Drug Class

By Disease Type

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online stores

By Country

  • China Uveitis Treatment Market
  • Japan Uveitis Treatment Market
  • India Uveitis Treatment Market
  • South Korea Uveitis Treatment Market
  • Singapore Uveitis Treatment Market
  • Malaysia Uveitis Treatment Market
  • Rest of Asia Pacific Uveitis Treatment Market

Companies Profiled

  • AbbVie, Inc.
  • Alimera Sciences, Inc.
  • Enzo Biochem, Inc.
  • Amgen, Inc.
  • Bausch Health Companies, Inc.
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • TopiVert Ltd.
  • Novartis AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Uveitis Treatment Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale